Skip to content
Triangle logo TriangleGet started
← Full study record

NCT03506386 · ADVERSE EVENTS

Adverse events

Multiple Myeloma (MM) Profile in Brazil: A Retrospective Observational Analysis · Source last updated 2021-02-08

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

Adverse events occurred during the study; they are not necessarily caused by treatment. Serious events are not interchangeable with severe/grade 3–4 events. These safety populations may differ from efficacy populations.

Collection time frame
From diagnosis up to the end of this study (up to 11.7 years)
Other-event reporting threshold
0%

Only deaths were collected, and data of adverse events or adverse drug reactions were not collected as part of the study database.

Participants affected / participants at risk, as reported
Safety groupSerious eventsOther eventsDeaths
Multiple Myeloma Participants

Participants with MM were observed retrospectively since the diagnosis up to death or lost to follow-up within the eligibility window of time (between January 1, 2008 and December 31, 2016), in this study.

0 / 00 / 0436 / 943

Group identifiers: EG000: Multiple Myeloma Participants

Serious adverse events

Event terms and counts are source-reported; expand to read more. A reporting threshold may omit less frequent events.

    Other reported adverse events

    Event terms and counts are source-reported; expand to read more. A reporting threshold may omit less frequent events.

      Complete source fields
      description
      Only deaths were collected, and data of adverse events or adverse drug reactions were not collected as part of the study database.
      event Groups
      1. deaths Num Affected
        436
        deaths Num At Risk
        943
        description
        Participants with MM were observed retrospectively since the diagnosis up to death or lost to follow-up within the eligibility window of time (between January 1, 2008 and December 31, 2016), in this study.
        id
        EG000
        other Num Affected
        0
        other Num At Risk
        0
        serious Num Affected
        0
        serious Num At Risk
        0
        title
        Multiple Myeloma Participants
      frequency Threshold
      0
      time Frame
      From diagnosis up to the end of this study (up to 11.7 years)

      Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

      Preserved source evidence · Not medical advice